New overdose drug CS-1103 heads to human testing
NCT ID NCT07459166
First seen Mar 19, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study tests a new drug called CS-1103 in 16 healthy adults who have used opioids before. Participants receive fentanyl (a strong painkiller) along with naloxone (an overdose reversal drug) and then CS-1103 or a placebo. The goal is to see if CS-1103 is safe and how it affects the body's processing of fentanyl.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FENTANYL OVERDOSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
California Clinical Trials Medical Group
Glendale, California, 91206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.